Litcius/Paper detail

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

Andrew Menzies‐Gow, Michael E. Wechsler, Christopher E. Brightling, Stephanie Korn, Jonathan Corren, Elliot Israel, Geoffrey Chupp, Artur Bednarczyk, Sandhia Ponnarambil, Scott Caveney, Gun Almqvist, Monika Gołąbek, Linda Simonsson, Kaitlyn Lawson, Karin Bowen, Gene Colice, Jorge Lima Hetzel, Jussara Fiterman, Adelmir Souza Machado, Martti Antila, Marina Andrade Lima, Suzana Erico Tanni Minamoto, Daniela Cavalet Blanco, Patrícia Gomes de Matos Bezerra, Pierre-Alain Houle, Catherine Lemière, Lyle Melenka, Richard Leigh, Patrick Mitchell, Syed Anees, Bonavuth Pek, Guy Chouinard, Amarjit Cheema, William H. Yang, George Philteos, Pascal Chanez, Arnaud Bourdin, Gilles Devouassoux, Camille Taillé, Frédéric de Blay, Christophe Leroyer, Antoine Beurnier, Gilles Garcia, Pierre‐Olivier Girodet, F.–X. Blanc, A. Magnan, Stéphanie Wanin, J. Just, R. Linde, Stefan Zielen, Karin Förster, Christian Geßner, Margret Jandl, Roland Buhl, Stephanie Korn, Marc Oliver Kornmann, Anneliese Linnhoff, Andrea Ludwig-Sengpiel, Martin Ehlers, Tibor Schmoller, Heiner Steffen, Martin Hoffmann, J Kirschner, Olaf Schmidt, Tobias Welte, Hilke Temme, Ori Wand, Amir Bar‐Shai, Gabriel Izbicki, Neville Berkman, Gershon Fink, David Shitrit, Yochai Adir, Piotr Kuna, Barbara Rewerska, Ewa Pisarczyk-Bogacka, О М Курбачева, Sergey L Mikhailov, M.P. Vasilev, Alexander Emelyanov, Siraj Wali, Amr S. Albanna, Richard N. van Zyl-Smit, Ismail Abdullah, Ismail Abdullah, David Bernhardi, Farzana Hoosen, Elvis M. Irusen, Ismail Kalla, Deepak Lakha, Essack Mitha, Visvakuren Naidoo, Haylene Nell, Trevenesan Padayachee, Jeevren Reddy, Friedrich Petrick, Eugene van der Walt, Zubar Fazal Ahmed Vawda, Hae‐Sim Park, Sang Haak Lee

2023The Lancet Respiratory Medicine143 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePlaceboAdverse effectAsthmaClinical endpointExacerbationRandomized controlled trialClinical trialPediatricsPhysical therapyConfidence intervalIntention-to-treat analysisInternal medicineAlternative medicinePathologyAsthma and respiratory diseasesAllergic Rhinitis and SensitizationDermatology and Skin Diseases
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study | Litcius